Srs Capital Advisors, Inc. Bio Techne Corp Transaction History

Srs Capital Advisors, Inc.

$1.95 Billion
Q2 2025

A detailed history of Srs Capital Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 14,902 shares of TECH stock, worth $922,731. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,902

Previous 15,326 2.77%

Holding current value

$922,731

Previous $898,000 14.7%

% of portfolio

0.04%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$46.66 - $58.38 $19,783 - $24,753	-424 Reduced 2.77%	14,902 $766,000
Q1 2025 May 14, 2025	SELL	$58.47 - $78.75 $156,641 - $210,971	-2,679 Reduced 14.88%	15,326 $898,000
Q4 2024 Feb 05, 2025	BUY	$66.37 - $78.17 $2,853 - $3,361	43 Added 0.24%	18,005 $1.3 Million
Q3 2024 Nov 06, 2024	BUY	$70.96 - $82.35 $10,218 - $11,858	144 Added 0.81%	17,962 $1.44 Million
Q2 2024 Aug 06, 2024	BUY	$62.12 - $84.15 $147,472 - $199,772	2,374 Added 15.37%	17,818 $1.28 Million
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $36,354 - $42,476	551 Added 3.7%	15,444 $1.09 Million
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $41,524 - $61,480	786 Added 5.57%	14,893 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $632,527 - $837,686	9,368 Added 197.68%	14,107 $960,000
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $45,509 - $53,049	617 Added 14.97%	4,739 $386,000
Q1 2023 May 16, 2023	BUY	$71.62 - $86.62 $9,668 - $11,693	135 Added 3.39%	4,122 $305,000
Q4 2022 Feb 24, 2023	BUY	$80.67 - $352.29 $242,332 - $1.06 Million	3,004 Added 305.6%	3,987 $330,000
Q3 2022 Nov 03, 2022	SELL	$282.54 - $391.85 $8,193 - $11,363	-29 Reduced 2.87%	983 $279,000
Q2 2022 Aug 22, 2022	BUY	$322.67 - $449.65 $18,714 - $26,079	58 Added 6.08%	1,012 $351,000
Q1 2022 May 12, 2022	BUY	$353.85 - $487.79 $56,616 - $78,046	160 Added 20.15%	954 $413,000
Q3 2021 Nov 05, 2021	BUY	$444.87 - $538.88 $4,003 - $4,849	9 Added 1.15%	794 $385,000
Q2 2021 Aug 02, 2021	SELL	$387.35 - $450.26 $72,821 - $84,648	-188 Reduced 19.32%	785 $353,000
Q4 2020 Feb 03, 2021	BUY	$246.9 - $321.87 $2,222 - $2,896	9 Added 0.93%	973 $309,000
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $13,468 - $16,411	58 Added 6.4%	964 $239,000
Q2 2020 Aug 06, 2020	BUY	$185.43 - $279.56 $48,026 - $72,406	259 Added 40.03%	906 $239,000
Q1 2020 May 13, 2020	SELL	$161.17 - $221.51 $2,901 - $3,987	-18 Reduced 2.71%	647 $123,000
Q4 2019 Feb 07, 2020	SELL	$189.68 - $222.09 $31,676 - $37,089	-167 Reduced 20.07%	665 $146,000
Q3 2019 Nov 01, 2019	BUY	$183.56 - $216.72 $26,065 - $30,774	142 Added 20.58%	832 $163,000
Q2 2019 Aug 08, 2019	BUY	$188.72 - $215.43 $104,739 - $119,563	555 Added 411.11%	690 $144,000
Q3 2018 Nov 06, 2018	BUY	$147.44 - $204.11 $19,904 - $27,554	135 New	135 $28,000

Others Institutions Holding TECH

# of Institutions

614

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.43B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Bio Techne Corp Transaction History